Drug Product Technologies, Amgen, Inc., Thousand Oaks, California 91320.
Biopharmaceutics and Specialty Dosage Forms, Pharmaceutical Sciences and Clinical Supply, Merck & Company, Inc., West Point, Pennsylvania 19486.
J Pharm Sci. 2018 Jan;107(1):18-23. doi: 10.1016/j.xphs.2017.08.015. Epub 2017 Aug 26.
Physiologically based oral absorption models are in silico tools primarily used to guide formulation development and project the clinical performance of formulation variants. This commentary briefly discusses additional oral absorption model applications, focusing on gut-level drug interactions. Gut-level drug interactions can involve drug degradation, metabolic enzymes, transporters, gastrointestinal motility modulators, acid-reducing agents, and food. The growth in publications reporting physiologically based oral absorption model utilization and successful pharmacokinetic prediction (e.g., after acid-reducing agents or food coadministration) indicate that oral absorption models have achieved a level of maturity within the industry particularly over the past 15 years. Provided appropriate data and model validation, oral absorption modeling/simulation may serve as a surrogate for clinical studies by providing both mechanistic and quantitative understanding of oral delivery considerations on pharmacokinetics.
生理相关的口服吸收模型是一种基于计算的工具,主要用于指导制剂的开发并预测制剂变异体的临床性能。本文简要讨论了其他口服吸收模型的应用,重点是肠道水平的药物相互作用。肠道水平的药物相互作用可能涉及药物降解、代谢酶、转运蛋白、胃肠道动力调节剂、胃酸抑制剂和食物。越来越多的出版物报告了生理相关的口服吸收模型的应用和成功的药代动力学预测(例如,在胃酸抑制剂或食物共给药后),这表明口服吸收模型在行业内已经达到了一定的成熟水平,尤其是在过去的 15 年里。如果提供了适当的数据和模型验证,口服吸收建模/模拟可以通过提供对药代动力学的口服传递考虑因素的机制和定量理解,作为临床研究的替代方法。